MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$7,438K
Free Cash flow
$7,353K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Prepaid expenses and other curre...
Accounts payable
Amortization of other intangible...
Others
Negative Cash Flow Breakdown
Accrued expenses and other curre...
Accounts receivable, net
Inventory
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net (loss) income
-5,287
-13,102
11,127
-7,277
Amortization of patent formulations
2,416
2,705
2,704
4,576
Amortization of other intangibles
10,820
10,854
10,905
21,823
Inventory write-off and disposal
203
2,087
677
2,804
Depreciation of fixed assets
82
77
89
179
Amortization of debt issuance costs
287
287
288
3,314
Deferred taxes
-4,360
6,016
-3,295
-1,444
Tax receivable agreement liability adjustment
-
2,666
9,452
-
Share-based compensation expense
3,517
3,593
3,311
6,381
Acquisition-related costs in investing activities
-
23
9,282
-
Other
-606
-866
-236
-641
Accounts receivable, net
8,757
-20,193
16,995
17,696
Inventory
6,493
-10,524
-3,961
5,988
Prepaid expenses and other current assets
-46,160
-1,468
1,090
49,162
Accounts payable
21,041
-15,362
-1,407
14,653
Accrued expenses and other current liabilities
-52,476
5,320
-2,837
47,863
Other assets and liabilities
260
212
-498
2,680
Net cash provided by (used in) operating activities
7,499
32,671
8,002
17,987
Purchase of property and equipment
146
109
71
151
Acquisition-related costs
-
46
10,587
-
Purchase of intangible assets
-
0
-
-
Purchase and development of software
142
163
305
1,174
Net cash used in investing activities
-288
-318
-10,963
-1,325
Proceeds from exercise of stock options
227
0
0
527
Payment related to shares withheld to cover tax withholding obligations for options and for sars-Employee Stock Option
-
0
-
-
Payments for shares withheld and retired to cover tax withholding obligation for rsus
-
-
-
0
Payment related to shares withheld to cover tax withholding obligations for options and for sars-Stock Appreciation Rights SARS
-
0
-
-
Payments made pursuant to tax receivable agreement
-
0
0
12,129
Principal payments of 2022 term loan facility
0
0
0
301,688
Net cash provided by (used in) financing activities
227
0
0
-313,290
Net increase (decrease) in cash and cash equivalents
7,438
32,353
-2,961
-296,628
Cash and cash equivalents - beginning of period
318,731
286,378
585,967
-
Cash and cash equivalents - end of period
326,169
318,731
286,378
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Prepaid expenses and
other current assets
-$46,160K
Proceeds from exercise of
stock options
$227K
Accounts payable
$21,041K
Amortization of other
intangibles
$10,820K
Share-based compensation
expense
$3,517K
Amortization of patent
formulations
$2,416K
Other
-$606K
Amortization of debt issuance
costs
$287K
Inventory write-off and
disposal
$203K
Depreciation of fixed assets
$82K
Net cash provided by
(used in) operating...
$7,499K
Net cash provided by
(used in) financing...
$227K
Canceled cashflow
$77,633K
Net increase
(decrease) in cash and cash...
$7,438K
Canceled cashflow
$288K
Accrued expenses and
other current...
-$52,476K
Accounts receivable, net
$8,757K
Inventory
$6,493K
Net (loss) income
-$5,287K
Deferred taxes
-$4,360K
Other assets and
liabilities
$260K
Net cash used in
investing activities
-$288K
Purchase of property and
equipment
$146K
Purchase and development
of software
$142K
Buy us a coffee
OLAPLEX HOLDINGS, INC. (OLPX)
OLAPLEX HOLDINGS, INC. (OLPX)